Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: F31CA192805-01
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: T32CA174648
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: T32CA190216
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: 5F31CA247211
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: AWD-183294-RS
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: NIH P30CA046934
National Institutes of Health (NIH) National Cancer Institute (NCI)
Grant: RSG-13-060-01-TBE
NCI NIH HHS
Grant: P30 CA046934
NCI NIH HHS
Grant: F31 CA247211
National Institutes of Health
Grant: 3T32CA174648-02S1
Training in Translational Research of Lung, Head and Neck Cancer
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 1F31CA247211-01
The Regulation of Apoptosis by Cooperative Src and MAPK Signaling in Thyroid Cancer
National Institutes of Health
Grant: 1F31CA192805-01
Elucidating Mechanisms of Resistance to Src Inhibition in Thyroid Cancer
National Institutes of Health
Grant: 5T32CA190216-03
Training Program in Cancer Biology
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals